Condensed Consolidated Statements of Equity - USD ($) shares in Thousands, $ in Thousands |
Global Medical REIT Inc. [Member] |
Common Stock [Member] |
Preferred Stock [Member] |
Additional Paid-in Capital [Member] |
Accumulated Deficit [Member] |
Accumulated Other Comprehensive Loss [Member] |
Noncontrolling Interest [Member] |
Total |
|---|---|---|---|---|---|---|---|---|
| Balances at Dec. 31, 2019 | $ 430,270 | $ 44 | $ 74,959 | $ 433,330 | $ (71,389) | $ (6,674) | $ 30,083 | $ 460,353 |
| Balance (in shares) at Dec. 31, 2019 | 43,806 | 3,105 | ||||||
| Net income | 2,710 | 2,710 | 107 | 2,817 | ||||
| LTIP Units and OP Units redeemed for common stock | 6,890 | 6,890 | (6,890) | |||||
| LTIP Units and OP Units redeemed for common stock (in shares) | 472 | |||||||
| Change in fair value of interest rate swap agreements | (13,958) | (13,958) | (13,958) | |||||
| Stock-based compensation expense | 922 | 922 | ||||||
| Dividends to common stockholders | (8,856) | (8,856) | (8,856) | |||||
| Dividends to preferred stockholders | (1,455) | (1,455) | (1,455) | |||||
| Dividends to noncontrolling interest | (1,033) | (1,033) | ||||||
| Balances at Mar. 31, 2020 | 415,601 | $ 44 | $ 74,959 | 440,220 | (78,990) | (20,632) | 23,189 | 438,790 |
| Balances (in shares) at Mar. 31, 2020 | 44,278 | 3,105 | ||||||
| Balances at Dec. 31, 2020 | 444,805 | $ 49 | $ 74,959 | 504,789 | (116,773) | (18,219) | 12,955 | 457,760 |
| Balance (in shares) at Dec. 31, 2020 | 49,461 | 3,105 | ||||||
| Net income | 3,211 | 3,211 | 112 | 3,323 | ||||
| Issuance of shares of common stock, net | 144,172 | $ 12 | 144,160 | 144,172 | ||||
| Issuance of shares of common stock, net (in shares) | 11,333 | |||||||
| Change in fair value of interest rate swap agreements | 3,631 | 3,631 | 3,631 | |||||
| Stock-based compensation expense | 1,715 | 1,715 | ||||||
| Dividends to common stockholders | (12,463) | (12,463) | (12,463) | |||||
| Dividends to preferred stockholders | (1,455) | (1,455) | (1,455) | |||||
| Dividends to noncontrolling interest | (864) | (864) | ||||||
| Balances at Mar. 31, 2021 | $ 581,901 | $ 61 | $ 74,959 | $ 648,949 | $ (127,480) | $ (14,588) | $ 13,918 | $ 595,819 |
| Balances (in shares) at Mar. 31, 2021 | 60,794 | 3,105 |
| X | ||||||||||
- Definition Number of new common stock issued during the period. No definition available.
|
| X | ||||||||||
- Definition Equity impact of the value of new common stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. No definition available.
|
| X | ||||||||||
- Definition Other Comprehensive Income Loss Change In Fair Value Of Interest Rate Swap Agreement No definition available.
|
| X | ||||||||||
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. No definition available.
|
| X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The gross value of stock issued during the period upon the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|